Njengamaqonga amatsha ophuhliso olukhawulezayo lwamachiza kunye nokuphuculwa kwezakhiwo zemodeli zokuvavanya ukusebenza kwechiza kunye netyhefu, i-organoids inamandla okuguqula. Iindlela zokufunyanwa kweziyobisi zesiNtu azibalulekanga kangako kwaye azanelanga ukuhambisana nesantya esikhawulezayo senkqubela phambili yesayensi yobomi. Ii-Organoids kuqikelelwa ukuba zibonise intengiso eyandayo kwishishini lokufunyanwa kweziyobisi.
Imfuno yeendlela zokuvavanya kwangaphambili zonyukile ngenxa yenkqubela phambili kunyango lwamachiza olufana nonyango lobuqu kunye nokwandisa uphando lwezonyango ukuchonga amayeza amatsha kwangaphambili. -vitro' iimeko ezisondele kancinci kwiimeko zendalo zendalo.
Ngokwe-International Federation of Pharmaceutical Manufacturers and Societies, uphando lwangaphambi kweklinikhi lubalelwa malunga ne-22% yeendleko zizonke zemveliso yamachiza. Ukusetyenziswa kwe-organoids ekuphuhliseni iziyobisi kunciphisa inkqubo kwaye konga imali, okukhokelela kwimfuno enkulu ye-organoids.
Ngokumalunga nemveliso, i-organoids yamathumbu kulindeleke ukuba ibhalise imfuno ephezulu, ibalelwa ngaphezulu kwe-36% yokuthengisa kwimarike. Ngelixa ukusetyenziswa kwee-organoids kulindeleke ukuba kuphakame kakhulu kwibhanki yebhayoloji.
Izinto eziphambili eziThathayo kwiSifundo seMarike ye-Organoids
- Imakethi ye-organoids iya kubonisa ukukhula okuqinileyo, ukubhalisa ngaphezulu kwe-14% CAGR phakathi kuka-2021 no-2031.
- Ukwandiswa kwecandelo lamayeza kunye notyalo-mali kumanyathelo ophando kuya kwenza ukuba i-akhawunti yase-US ithengise ngaphezu kwe-95% kuMntla Melika.
- I-UK iya kuvela njengeyona marike iphambili, ibonisa ukukhula okungaphezulu kwe-20% yoy ngo-2021
- IJamani kunye neFransi kulindeleke ukuba zivele njengezinye iimarike ezinengeniso ngaphakathi e-UK
- I-China iya kuhlala iyimakethi ekhokelayo yee-organoids eMpuma ye-Asia, nangona kunjalo, imakethi yaseJapan iya kubhalisa isantya esiphezulu sokukhula
"Amandla eenkcubeko ze-3D-organoid ukulinganisa ukusebenza kwelungu kunye nokwanda kokwamkelwa kwetekhnoloji ye-organoid ukuze isetyenziswe kuluhlu lwezicelo, kubandakanya uguquko lwemfuza kunye nokunye kulindeleke ukuba kuqhube ukukhula kwemarike ye-Organoids," utshilo uMhlalutyi weFMI.
Ukuhlala uphambi kwabantu okhuphisana nabo, cela isampuli- https://www.futuremarketinsights.com/reports/sample/rep-gb-8106
Inkxaso-mali yophando lwesayensi yobomi kunye notyalo-mali kwiimveliso ze-Organoids ukwandisa iiprojekthi ezahlukeneyo kunye nabasebenzi abaqeshwayo yeyona nto iphambili ekulindeleke ukuba ikhulise ukukhula kwemarike ye-organoids.
Umzekelo, isixa sisonke sezibonelelo zophando ezinikezelwe ngamaZiko ezeMpilo eSizwe (NIH) e-US idlule i-US$251 yezigidi kwiminyaka emihlanu (2015 ukuya ku-2019).
Abadlali abaphambili kwi-Organoids bangena kwi-Strategic AllianceAbadlali abaphezulu bagxile ekwandiseni indawo yeshishini labo ngokufumana izinto. Izinto ezithengiweyo zibonelela inkampani ngokubambelela ngokuqinileyo kwiimveliso ezintsha, ubudlelwane babaxhasi bomthengi, kunye neendawo ezintsha zejografi ukucofa amandla okuthengisa. Abavelisi abaphambili bajolise ekufumaneni iimveliso ezaziwayo kunye netekhnoloji ekulindeleke ukuba ibe nengeniso eyimpumelelo. Oku kukwanceda ishishini ukuba likhule libe ziimarike ezintsha ezisahlumayo ngelixa zikwaphuhlisa esele zikhona.
Umzekelo, ngoSeptemba ka-2020, iMemorandam yokuQonda (i-MoU) yatyikitywa yi-BGI-Qingdao kunye ne-Ubrecht Organoid Technology (HUB) ukuphuhlisa iziko elidibeneyo le-Next Generation Diagnostics (NGD) e-China ukuphucula ukhathalelo lomntu, unyango olungcono kunye nonyango, kunye nophuhliso olukhawulezayo lwamayeza amatsha akhuselekileyo.I-HUB kunye ne-BGI iya kudibanisa izakhono zabo ezincedisayo kunye nobuchwepheshe ukuqhubela phambili nokuphucula kunye nokubandakanya i-HUB Organoid Technology njengeemvavanyo zokuxilonga kwangaphambili, okuvumela ukubikezelwa kwempendulo yonyango oluchanekileyo lwesigulane, ekuqaleni ngokugxila kumhlaza.
Ngenxa yokonyuka kogxininiso kuphando lwe-oncological kunye nokunyuka kwenkcitho ye-R&D, imakethi ye-organoids yehlabathi kulindeleke ukuba yande kwixesha lengqikelelo. Imakethi ye-Organoids inokhuphiswano kakhulu ebonisa ubukho babadlali abaninzi. Ngenxa yotyalo-mali oluphezulu olufunekayo ukwakha indawo yokuvelisa i-Organoids, iinkampani ezixuba amayeza ziya zijonge ukukhupha inkqubo.Abadlali bemarike abaphambili abagutyungelwe yiFMI babandakanya iSTEMCELL Technologies Inc., Cellesce Ltd., DefiniGEN, Qgel, Hubrecht Organoid Technology, OcellO BV ukuqinisa izikhundla zabo ngokudityaniswa, ukufunyanwa kunye nokuqaliswa kwemveliso entsha.
Ukuqonda okuBalulekileyo kwiMarike ye-OrganoidsI-Future Market Insights, kunikezelo lwayo olutsha, ibonelela ngohlalutyo olungakhethi cala kwimakethi ye-organoids, inikezela ngedatha yemfuno yembali (2016-2020) kunye neenkcukacha zoqikelelo lwexesha elisuka ku-2021-2031. Uphononongo lutyhila ulwazi olunyanzelisayo kwintengiso esekwe kuhlobo lwemveliso (i-organoids yamathumbu, i-hepatic organoids, i-pancreatic organoids, i-colorectal organoids, kunye ne-neural organoids), isicelo (ibhanki yebhayoloji, uphando lwebhayoloji kunye nokufunyanwa kweziyobisi, amayeza okuhlaziya, uphando lomhlaza, kunye nonyango. izixhobo), kunye nomsebenzisi wokugqibela (iinkampani zebiopharmaceutical, imibutho yophando lwekhontrakthi, kunye nezifundiswa kunye namaziko ophando) kuyo yonke imimandla emikhulu esixhenxe.
Imarike yeOrganoids ngokweCandeloNgohlobo lweMveliso, imarike ye-Organoids yahlulwe ngolu hlobo:
- I-Organoids yamathumbu
- I-Hepatic Organoids
- I-Pancreatic Organoids
- I-Organoids yeColorectal
- I-Neural Organoids
- abanye
NgeSicelo, imarike ye-Organoids yahlulwe ngolu hlobo:
- I-Bio-banking
- Uphando lweBiomedical kunye noFundo lweziyobisi
- Uncedo lweMpilo
- Uphando ngomhlaza
- Izixhobo zonyango
- abanye
NgoMsebenzisi wokugqibela, imakethi ye-Organoids yahlulwe njenge:
- Iinkampani zeBiopharmaceutical
- Imibutho yoPhando lwekhontrakthi
- Amaziko emfundo noPhando
Ngommandla, imarike ye-Organoids yahlulwe ngolu hlobo:
- amantla Emelika
- ilatin America
- iYurophu
- EMpuma Asia
- WaseMzantsi Asia
- Oceania
- UMbindi Mpuma kunye neAfrika (MEA)
Fumana iNgxelo eFanelweyo ukuze ifanise iimfuno zakho, Buza kwiNgcali yoPhando lweMarike- https://www.futuremarketinsights.com/ask-question/rep-gb-8106
INTO ONOKUYITHATHA KWELI NQAKU:
- “Capability of 3D-organoid cultures to mimic organ functionality as well as increasing adoption of the organoid technology for use in a range of applications, including genetic mutation and other is expected to drive the growth of Organoids market” says the FMI Analyst.
- For instance, in September 2020,a Memorandum of Understanding (MoU) was signed by BGI-Qingdao and Ubrecht Organoid Technology (HUB) to develop a joint Next Generation Diagnostics (NGD) centre in China to improve personalised care, better treatments and cures, and faster development of new safe medicines.
- As a result of increased emphasis on oncological research and increased R&D spending, the global organoids market is expected to expand over the forecast period.
